FdaApplication
ANDA 213105
Identifiers
- fda_app_no: ANDA213105
Properties
| Property | Value |
|---|---|
| applicant_name | CATALENT PHARMA SOLUTIONS LLC |
| application_type | ANDA |
| approval_date | 2020-09-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 10MG | CAPSULE;ORAL |
1 product